Skip to main content

4 Result(s)

within Yoshiaki Okuma Remove this filter

and

  1. Article

    Open Access

    Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study

    Tenascin-C (TN-C) is an extracellular matrix glycoprotein related to tissue inflammation. Our previous retrospective study conducted in 2016 revealed that the serum tenascin-C level was higher in patients with...

    Yukako Yoshikane, Yoshiaki Okuma, Tatsuki Miyamoto… in Pediatric Rheumatology (2021)

    Download PDF (882 KB) View Article

  2. No Access

    Article

    Correlation between expression of oncogene products and resistance to anticancer drugs in cultured ovarian cancer cell lines

    Despite recent advances in the application of chemotherapy to ovarian cancer, the development of alternative therapies that retain activity against drug-resistant-tumors remains a high priority. We analyzed a ...

    Yoshiaki Okuma, Kazushige Kiguchi, Yutaka Koshitaka, Asami Okamura… in Human Cell (2003)

  3. No Access

    Article

    Establishment and characterization of a human ovarian granulosa tumor cell line (HSOGT)

    We successfully established a novel ovarian granulosa tumor cell line (HSOGT). The tumor tissue of the ovary was derived from a 25 year-old Japanese woman under her consent. The cell line was maintained for ov...

    Haruhiro Kondo, Kazushige Kiguchi, Asami Okamura, Yoshiaki Okuma… in Human Cell (2003)

  4. No Access

    Article

    Establishment and characterization of a cell-line originated from human mucinous cystadenocarcinoma of the ovary

    We recently established a cell line (designated 371M) derived from an ovarian mucinous cystadenocarcinoma. The tumor cells were obtained from the ascitic fluid of a 54-year-old Japanese woman while she was und...

    Sojiro Sato, Yoichi Kobayashi, Yoshiaki Okuma, Haruhiro Kondo, Yosuke Kanishi… in Human Cell (2002)